These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 2275882)

  • 1. Image cytometry of aneuploidy, growth fraction (MoAb Ki-67) and hormone receptors (ER, PR) immunocytochemical assays in breast carcinomas.
    Charpin C; Andrac L; Lavaut MN; Andonian C; Fraterno M; Devictor B; Perez-Castillo A; Bonnier P; Piana L
    Anal Cell Pathol; 1990 Oct; 2(6):357-71. PubMed ID: 2275882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Immunohistochemical detection of estrogen receptors and image analysis (SAMBA 200) in breast carcinomas].
    Charpin C; Martin PM; Andrac L; Lavaut MN; Vacheret H; Habib MC; Toga M
    Ann Pathol; 1988; 8(3):196-210. PubMed ID: 3178938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiparametric evaluation (SAMBA) of growth fraction (monoclonal Ki67) in breast carcinoma tissue sections.
    Charpin C; Andrac L; Vacheret H; Habib MC; Devictor B; Lavaut MN; Toga M
    Cancer Res; 1988 Aug; 48(15):4368-74. PubMed ID: 3390833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
    Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
    Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multiparametric analysis (SAMBA 200) of the progesterone receptor immunocytochemical assay in nonmalignant and malignant breast disorders.
    Charpin C; Jacquemier J; Andrac L; Vacheret H; Habib MC; Devictor B; Lavaut MN; Toga M
    Am J Pathol; 1988 Aug; 132(2):199-211. PubMed ID: 2456699
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative DNA analysis in breast carcinomas: a comparison between image analysis and flow cytometry.
    Lee AK; Dugan J; Hamilton WM; Cook L; Heatley G; Kamat B; Silverman ML
    Mod Pathol; 1991 Mar; 4(2):178-82. PubMed ID: 2047381
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quantitative DNA analysis and proliferation in breast carcinomas. A comparison between image analysis and flow cytometry.
    Lee AK; Wiley B; Dugan JM; Hamilton WH; Loda M; Heatley GJ; Cook L; Silverman ML
    Pathol Res Pract; 1992 Jun; 188(4-5):428-32. PubMed ID: 1329051
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [DNA content analysis of breast cancer cells recognized by monoclonal antibody].
    Zhu LW
    Zhonghua Zhong Liu Za Zhi; 1993 Sep; 15(5):347-50. PubMed ID: 8174478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for prediction of poor short term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(2B):1417-23. PubMed ID: 9137508
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multivariate analysis of bcl-2, apoptosis, P53 and HER-2/neu in breast cancer: a short-term follow-up.
    el-Ahmady O; el-Salahy E; Mahmoud M; Wahab MA; Eissa S; Khalifa A
    Anticancer Res; 2002; 22(4):2493-9. PubMed ID: 12174951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Growth fraction (Ki67), ploidy balance and proliferation index in tumors of the urogenital tract and breast].
    Charpin C; Habib MC; Piana L; Rampal M; Andrac L; Vacheret H; Martini P; Perez-Castillo M; Lavaut MN; Toga M
    Ann Pathol; 1989; 9(5):331-9. PubMed ID: 2610776
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The immunohistochemical growth fraction (Ki-67) of breast cancers: relations to tumor spread, tumor morphology and receptor testing].
    Weikel W; Beck T; Rosenthal H; Herzog R
    Geburtshilfe Frauenheilkd; 1989 Mar; 49(3):277-82. PubMed ID: 2566552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multivariate analysis of DNA ploidy, p53, c-erbB-2 proteins, EGFR, and steroid hormone receptors for short-term prognosis in breast cancer.
    Eissa S; Khalifa A; el-Gharib A; Salah N; Mohamed MK
    Anticancer Res; 1997; 17(4B):3091-7. PubMed ID: 9329609
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous immunohistochemical and biochemical hormone receptor assessment in breast cancer provides complementary prognostic information.
    Biesterfeld S; Schröder W; Steinhagen G; Koch R; Veuskens U; Schmitz FJ; Handt S; Böcking A
    Anticancer Res; 1997; 17(6D):4723-9. PubMed ID: 9494596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
    Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
    Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunohistochemical detection of p53 protein expression in breast cancer in young Kuwaiti women.
    Temmim L; Baker H; Sinowatz F
    Anticancer Res; 2001; 21(1B):743-8. PubMed ID: 11299837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
    Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
    J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of the CD44 glycoprotein (lymphocyte-homing receptor) in untreated human breast cancer and its relationship to prognostic markers.
    de la Torre M; Heldin P; Bergh J
    Anticancer Res; 1995; 15(6B):2791-5. PubMed ID: 8669866
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunohistochemistry on cell blocks from fine-needle cytopunctures of primary breast carcinomas and lymph node metastases.
    Briffod M; Hacène K; Le Doussal V
    Mod Pathol; 2000 Aug; 13(8):841-50. PubMed ID: 10955449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between p53, c-erbB-2, and topoisomerase II alpha expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications.
    Rudolph P; Olsson H; Bonatz G; Ratjen V; Bolte H; Baldetorp B; Fernö M; Parwaresch R; Alm P
    J Pathol; 1999 Jan; 187(2):207-16. PubMed ID: 10365096
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.